Bibliographic information
GuidelineAbortion care guideline
Year of Publication2022
Issuing InstitutionWHO
Recommendation
Maintained
Originally developed
For both medical and surgical abortion at < 12 weeks: Recommend against anti-D immunoglobulin administration.
Recommended against
Strong
Certainty of evidence
Very low
Notes and Remarks
Remark:
- Standard of care applies for anti-D administration at gestational ages ≥ 12 weeks.
Implementation considerations
- Routine laboratory testing, including Rh testing, is not a requirement for abortion services at any gestational age.
- Determination of Rh status and the offer of anti-D prophylaxis are not considered prerequisites for early medical abortion at gestational ages before 12 weeks.
KEY HUMAN RIGHTS CONSIDERATIONS RELEVANT TO Rh ISOIMMUNIZATION
- States must ensure access to up-to-date scientific technologies necessary for women.
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Abortion care guideline, 2nd ed
Year2024
InstitutionWorld Health Organization